Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer

Prostate

Volumn 75, Issue 15, 2015, Pages 1718-1725

  Barry, Kathryn Hughes ^a   Moore, Lee E ^a   Liao, Linda M ^a   Huang, Wen Yi ^a   Andreotti, Gabriella ^a   Poulin, Matthew ^b   Berndt, Sonja I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EpigenDx   (United States)

Author keywords

global DNA methylation; pre diagnostic; prostate cancer; repetitive element

Indexed keywords

ADULT; ALU GENE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; GENE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; LINE I GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PYROSEQUENCING; RISK ASSESSMENT; AGED; ALU SEQUENCE; BLOOD; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; LONG INTERSPERSED REPEAT; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK;

AGED; ALU ELEMENTS; CASE-CONTROL STUDIES; DNA METHYLATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK;

EID: 84942818248     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23053     Document Type: Article

References (26)

1. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
2. Brothman AR, Swanson G, Maxwell TM, Cui J, Murphy KJ, Herrick J, Speights VO, Isaac J, Rohr LR,. Global hypomethylation is common in prostate cancer cells: A quantitative predictor for clinical outcome? Cancer Genet Cytogenet 2005; 156: 31-36.
3. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, De Marzo AM, Nelson WG,. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008; 68: 8954-8967.
4. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardõn A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N,. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: A case-control study. Lancet Oncol 2008; 9: 359-366.
5. Gao Y, Baccarelli A, Shu XO, Ji BT, Yu K, Tarantini L, Yang G, Li HL, Hou L, Rothman N, Zheng W, Gao YT, Chow WH,. Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study. Br J Cancer 2012; 106: 585-591.
6. Rusiecki JA, Al-Nabhani M, Tarantini L, Chen L, Baccarelli A, Al-Moundhri MS,. Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population. Epigenomics 2011; 3: 417-429.
7. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P, Chow WH, Moore LE,. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS ONE 2011; 6: e27361.
8. Di JZ, Han XD, Gu WY, Wang Y, Zheng Q, Zhang P, Wu HM, Zhu ZZ,. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. J Zhejiang Univ Sci B 2011; 12: 805-811.
9. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, Nesline MK, Ambrosone CB, Karpf AR,. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30: 1889-1897.
10. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ,. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010; 16: 1682-1689.
11. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT,. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 108-114.
12. Brennan K, Flanagan JM,. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 2012; 5: 1345-1357.
13. Torano EG, Petrus S, Fernandez AF, Fraga MF,. Global DNA hypomethylation in cancer: Review of validated methods and clinical significance. Clin Chem Lab Med 2012; 50: 1733-1742.
14. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP,. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.
15. Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD,. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005; 592: 147-154.
16. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21: 273S-309S.
17. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G,. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649.
18. Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE,. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Epigenetics 2013; 9: 404-415.
19. Karami S, Andreotti G, Liao LM, Pfeiffer RM, Weinstein SJ, Purdue MP, Hofmann JN, Albanes D, Mannisto S, Moore LE,. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Epigenetics 2015; 10: 282-292.
20. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, Gao YT, Nelson HH, Kelsey KT,. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 2012; 130: 1151-1159.
21. Florath I, Butterbach K, Muller H, Bewerunge-Hudler M, Brenner H,. Cross-sectional and longitudinal changes in DNA methylation with age: An epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet 2014; 23: 1186-1201.
22. Hou L, Wang H, Sartori S, Gawron A, Lissowska J, Bollati V, Tarantini L, Zhang FF, Zatonski W, Chow WH, Baccarelli A,. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer 2010; 127: 1866-1874.
23. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, Zanobetti A, Vokonas P, Wright RO, Baccarelli A, Schwartz J,. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011; 22: 437-447.
24. Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, Ferris JS, Santella RM, Terry MB,. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis 2012; 33: 1946-1952.
25. Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, Dalay N, Santella RM,. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 2010; 30: 2489-2496.
26. Li TH, Schmid CW,. Differential stress induction of individual Alu loci: Implications for transcription and retrotransposition. Gene 2001; 276: 135-141.